
news +insights
AbbVie Barceloneta Expansion: $217M Biologics Upgrade, 100 Jobs

AbbVie will invest $217 million to modernize and expand its biologics manufacturing campus in Barceloneta, Puerto Rico, Governor Jenniffer González-Colón and Department of Economic Development and Commerce (DDEC) Secretary Carlos J. Ríos Pierluisi announced on Wednesday, November 18, 2026 (Puerto Rico Federal Affairs Administration). The project is expected to add 100 jobs and retain 1,214 existing positions, with work running from 2026 through 2030 (News is My Business).
What Happened
The announcement was made in Barceloneta, on Puerto Rico's north coast (Puerto Rico Federal Affairs Administration). AbbVie said the expansion will increase production capacity, upgrade infrastructure and bring in manufacturing technologies, including artificial intelligence, to make current and future immunology and neuroscience medicines (News is My Business). Carlos Martis, AbbVie's site head in Puerto Rico, said the work will modernize the facilities to make next generation biologic products (Metro Puerto Rico).
The governor said the investment sends a strong message about the island's ability to compete for high value manufacturing, and noted that AbbVie evaluated other jurisdictions before choosing Puerto Rico (Metro Puerto Rico). El Nuevo Día reported that the company will build a new facility as part of the project (El Nuevo Día).
How the $217 Million Breaks Down
The investment comes from AbbVie's own capital (El Nuevo Día). Two outlets reported the same split:
- $121 million for machinery, equipment and technology (El Nuevo Día).
- $96 million for infrastructure and building improvements (Placeres).
The construction side of the project, at $96 million, is a sizable building and infrastructure program on its own, apart from the process equipment.
Incentives and Jobs
DDEC plans to provide $45.9 million in incentives through its Incentive Fund (Puerto Rico Federal Affairs Administration). Metro Puerto Rico reported that $36.3 million of that is for equipment and technology and $9.6 million for infrastructure (Metro Puerto Rico). News is My Business described the incentives as proposed and under consideration by DDEC (News is My Business).
The new positions will raise AbbVie's Puerto Rico workforce to 1,314 employees, with an estimated annual payroll of about $118.2 million tied to its island operations (Puerto Rico Federal Affairs Administration). The new roles are expected in engineering, automation, validation, quality assurance and advanced manufacturing (News is My Business).
Schedule
The Weekly Journal reported that construction is expected to begin this year, with the upgraded facilities fully operational by 2030 (The Weekly Journal). No general contractor, construction manager or design firm was named in the coverage reviewed.
AbbVie's Local Supply Chain
AbbVie spent $157 million with more than 170 Puerto Rico suppliers in 2025, according to its economic impact report (News is My Business). The company told Metro Puerto Rico that it buys more than $150 million a year from small and mid-size local businesses (Metro Puerto Rico).
The Barceloneta project is part of a broader AbbVie expansion. The company said it has announced $2.4 billion in new U.S. manufacturing investments over the previous 16 months, tied to more than 1,400 jobs across North Carolina, Illinois, Massachusetts, Arizona and Puerto Rico (News is My Business).
Where It Fits in the Pharma Building Wave
Drug manufacturers have been committing record sums to U.S. plants. WCG has tracked that pipeline in Pharma Campus Wave: Five U.S. Drug Plant Projects Total $13.15 Billion and, most recently, the groundbreaking of Eli Lilly's $3.5 billion Lehigh Valley plant. AbbVie's Barceloneta project is smaller and focused on modernizing an existing campus, which is typical of brownfield pharma work: phased upgrades inside an operating site rather than a new greenfield plant.
Implications for Owners, Developers, Contractors and Subs
- Work inside a running plant: modernization at an active biologics campus usually means phased shutdowns, strict gowning and cleanroom protocols, and close coordination with production schedules.
- Validation drives the schedule: with new hires planned in validation and quality assurance (News is My Business), contractors should expect commissioning, qualification and documentation to be a large part of closeout.
- Equipment heavy budget: more than half the spend is machinery, equipment and technology (El Nuevo Día), so process piping, electrical, controls and setting work will be central.
- Local subcontracting: AbbVie's existing spending with more than 170 island suppliers points to openings for Puerto Rico trade contractors and vendors (News is My Business).
What to Watch
- Final approval of the $45.9 million DDEC incentive package (News is My Business).
- Selection of a construction manager and design team, and details on the new building.
- Progress toward full operations by 2030 (The Weekly Journal).
Bottom Line
AbbVie's $217 million Barceloneta project pairs $121 million in equipment with $96 million in building and infrastructure work, adds 100 jobs and runs through 2030. It is a steady, process-intensive modernization job of the kind that keeps specialized pharma contractors busy between larger greenfield plants.
Key Questions
How much is AbbVie investing in Barceloneta?
AbbVie is investing $217 million in its Barceloneta, Puerto Rico biologics campus, including $121 million for equipment and technology and $96 million for infrastructure and building improvements (El Nuevo Día).
How many jobs will the AbbVie Barceloneta expansion create?
The AbbVie Barceloneta expansion is expected to create about 100 jobs and retain 1,214 existing positions, bringing AbbVie's Puerto Rico workforce to 1,314 (Puerto Rico Federal Affairs Administration).
When will the AbbVie Barceloneta project be finished?
Work on AbbVie's Barceloneta campus is expected to begin in 2026, with the upgraded facilities fully operational by 2030 (The Weekly Journal).
What incentives is Puerto Rico offering AbbVie?
Puerto Rico's DDEC plans to provide $45.9 million in incentives to AbbVie through its Incentive Fund (Puerto Rico Federal Affairs Administration).
Related Coverage
- Pharma Campus Wave: Five U.S. Drug Plant Projects Total $13.15 Billion
- Eli Lilly Lehigh Valley Plant: $3.5 Billion Obesity Drug Site Breaks Ground
- Pharma's $480 Billion U.S. Construction Wave: What Onshoring Means for Builders and Owners
Image credit: News is My Business. Image from the source article.
Sources
- Puerto Rico Federal Affairs Administration, Governor Announces $217 Million Investment by AbbVie to Expand Barceloneta Manufacturing Operations, https://www.prfaa.pr.gov/recent-press-releases/governor-announces-217-million-investment-by-abbvie-to-expand-barceloneta-manufacturing-operations
- News is My Business, AbbVie plans $217M expansion at Barceloneta plant, https://newsismybusiness.com/abbvie-plans-217m-expansion-at-barceloneta-plant/
- El Nuevo Día, AbbVie will invest $217 million in the expansion of its plant in Barceloneta, https://www.elnuevodia.com/english/business/story/abbvie-will-invest-217-million-in-the-expansion-of-its-plant-in-barceloneta/
- Metro Puerto Rico, AbbVie invertirá $217 millones en operaciones de Barceloneta, https://www.metro.pr/negocios/2026/11/19/abbvie-invertira-217-millones-en-operaciones-de-barceloneta-2
- The Weekly Journal, AbbVie to Invest $217 Million in Barceloneta Manufacturing Campus, https://www.wjournalpr.com/business/abbvie-to-invest-217-million-in-barceloneta-manufacturing-campus/article_cb164101-74d4-4204-8d51-68d87fb1cca9.html
- Placeres, Biofarmacéutica AbbVie Amplía Operaciones en Barceloneta, https://www.placerespr.com/biofarmaceutica-abbvie-amplia-operaciones-en-barceloneta/






